CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors

Grand-Guillaume, Joana; Mansi, Rosalba; Gaonkar, Raghuvir H.; Zanger, Sandra; Fani, Melpomeni; Eugster, Philippe J.; Beck Popovic, Maja; Grouzmann, Eric; Abid, Karim

doi:10.1186/s12967-023-04466-z

Journal of Translational Medicine

Article metrics
Last updated: Sat, 18 May 2024 18:43:46 Z

CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (^123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors

Access & Citations

916

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com